Sign inJoin waitlistJoin the waitlist

Mahesh Swaminathan

Assistant Professor · University of Texas M D Anderson Cancer Center

Credentials: · · · · · · · ·

History

University of Texas M D Anderson Cancer Center
Present

Roswell Park Comprehensive Cancer Center
2019–2022
University of Texas Health Science Center at Houston
2017–2019
Internal Medicine
University of Illinois
2014–2017
Bachelor of Medicine, Bachelor of Surgery
2008–2012

Research

Hematologic malignancies and Li-Fraumeni syndrome
Review · Cold Spring Harbor molecular case studies · 2019 · First of 13 authors · 64 citations
A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome
Haematologica · 2021 · First of 24 authors · 48 citations
Menin Inhibitors in Acute Myeloid Leukemia-What Does the Future Hold?
Review · The Cancer Journal · 2022 · First of 4 authors · 47 citations

Courtney DiNardo
23 papers
Hagop Kantarjian
22 papers
Tapan Kadia
22 papers
Guillermo Garcia-Manero
19 papers
Guillermo Bravo
18 papers
Elias Jabbour
17 papers
Nicholas Short
17 papers
Kelly Chien
16 papers
Naval Daver
16 papers
KS
Koji Sasaki
15 papers
Alexandre Bazinet
14 papers · 14 as a fellow
Danielle Hammond
14 papers

Clinical trials

Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD
Principal investigator · Recruiting · Phase 2
M.D. Anderson Cancer Center
2026–2030
A Phase 2 Study of INCB57643 (BET Inhibitor) in Combination With Ruxolitinib in JAK Inhibitor-naïve Patients With Myelofibrosis
Principal investigator · Withdrawn · Phase 2
M.D. Anderson Cancer Center
2024–2025